Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying key players in dark web marketplaces through Bitcoin transaction networks.

Scientific reports·2024
Same author

Macroscopic properties of buyer-seller networks in online marketplaces.

PNAS nexus·2023
Same author

Vaccines and more: The response of Dark Web marketplaces to the ongoing COVID-19 pandemic.

PloS one·2022
Same author

Central bank digital currencies risk becoming a digital Leviathan.

Nature human behaviour·2022
Same author

Emergence and structure of decentralised trade networks around dark web marketplaces.

Scientific reports·2022
Same author

Dark Web Marketplaces and COVID-19: before the vaccine.

EPJ data science·2021
Same journal

A cost-benefit analysis of the COVID-19 disease.

Oxford review of economic policy·2025
Same journal

Business in times of crisis.

Oxford review of economic policy·2025
Same journal

COVID-19 and public-sector capacity.

Oxford review of economic policy·2025
Same journal

Supply and demand shocks in the COVID-19 pandemic: an industry and occupation perspective.

Oxford review of economic policy·2025
Same journal

Social protection response to the COVID-19 crisis: options for developing countries.

Oxford review of economic policy·2025
Same journal

What is the meaning of (statistical) life? Benefit-cost analysis in the time of COVID-19.

Oxford review of economic policy·2025
See all related articles

Related Experiment Video

Updated: Jun 13, 2025

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.2K

Adaptive Targeted Infectious Disease Testing.

Maximilian Kasy1, Alexander Teytelboym1

  • 1Department of Economics, University of Oxford.

Oxford Review of Economic Policy
|June 12, 2025
PubMed
Summary
This summary is machine-generated.

This study optimizes epidemic testing strategies by balancing testing costs and quarantine decisions. The optimal policy targets individuals with intermediate infection probability, adjusting based on false quarantine or release costs for efficient resource allocation.

More Related Videos

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

7.9K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K

Related Experiment Videos

Last Updated: Jun 13, 2025

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.2K
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

7.9K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.7K

Area of Science:

  • Epidemiology
  • Public Health Resource Allocation
  • Infectious Disease Modeling

Background:

  • Epidemic management requires efficient allocation of costly testing resources.
  • Testing outcomes inform critical quarantine decisions, impacting disease spread.
  • Balancing testing costs against potential harms of false quarantine or release is essential.

Purpose of the Study:

  • To develop an efficient testing policy for managing epidemics with limited resources.
  • To determine optimal testing strategies based on individual infection probability and associated costs.
  • To address the dynamic trade-offs in testing when individuals arrive over time.

Main Methods:

  • Economic analysis of testing and quarantine decision-making.
  • Development of a myopic testing policy based on infection likelihood.
  • Formulation of a simple, near-optimal dynamic testing policy.

Main Results:

  • Optimal myopic policy targets individuals with intermediate infection probability.
  • High cost of false release favors testing low-probability individuals; high cost of false quarantine favors testing high-probability individuals.
  • A simple dynamic policy approximates optimal resource allocation over time.

Conclusions:

  • Efficient epidemic testing requires a nuanced approach, prioritizing individuals based on infection risk and cost-benefit analysis.
  • The proposed dynamic policy offers a practical solution for real-world implementation, considering imperfect testing and changing prevalence rates.
  • Strategic testing resource allocation is key to effective epidemic control.